TNF and inflammatory bowel disease: Parakkal et al. [13] reported that 3 RA patients treated with MTX and TNF inhibitors for 1.2 to 5 years as well as 22 patients with IBD receiving TNF inhibitors and azathioprine had hepatosplenic TCL in the FDA database, and 2 RA patients died of the disease.